141 related articles for article (PubMed ID: 28143883)
1. FZR1 loss increases sensitivity to DNA damage and consequently promotes murine and human B-cell acute leukemia.
Ishizawa J; Sugihara E; Kuninaka S; Mogushi K; Kojima K; Benton CB; Zhao R; Chachad D; Hashimoto N; Jacamo RO; Qiu Y; Yoo SY; Okamoto S; Andreeff M; Kornblau SM; Saya H
Blood; 2017 Apr; 129(14):1958-1968. PubMed ID: 28143883
[TBL] [Abstract][Full Text] [Related]
2. Loss of the mammalian APC/C activator FZR1 shortens G1 and lengthens S phase but has little effect on exit from mitosis.
Sigl R; Wandke C; Rauch V; Kirk J; Hunt T; Geley S
J Cell Sci; 2009 Nov; 122(Pt 22):4208-17. PubMed ID: 19861496
[TBL] [Abstract][Full Text] [Related]
3. The APC activator fizzy-related-1 (FZR1) is needed for preimplantation mouse embryo development.
Seah MK; Holt JE; García-Higuera I; Moreno S; Jones KT
J Cell Sci; 2012 Dec; 125(Pt 24):6030-7. PubMed ID: 23097041
[TBL] [Abstract][Full Text] [Related]
4. The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function.
Wan L; Chen M; Cao J; Dai X; Yin Q; Zhang J; Song SJ; Lu Y; Liu J; Inuzuka H; Katon JM; Berry K; Fung J; Ng C; Liu P; Song MS; Xue L; Bronson RT; Kirschner MW; Cui R; Pandolfi PP; Wei W
Cancer Discov; 2017 Apr; 7(4):424-441. PubMed ID: 28174173
[TBL] [Abstract][Full Text] [Related]
5. The APC/C activator FZR1 is essential for meiotic prophase I in mice.
Holt JE; Pye V; Boon E; Stewart JL; García-Higuera I; Moreno S; Rodríguez R; Jones KT; McLaughlin EA
Development; 2014 Mar; 141(6):1354-65. PubMed ID: 24553289
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the Anaphase Promoting Complex activator FZR1/CDH1 is required for Meiosis II entry in mouse male germ cell.
Tanno N; Kuninaka S; Fujimura S; Takemoto K; Okamura K; Takeda N; Araki K; Araki M; Saya H; Ishiguro KI
Sci Rep; 2020 Jun; 10(1):10094. PubMed ID: 32572094
[TBL] [Abstract][Full Text] [Related]
7. Functions of FZR1 and CDC20, activators of the anaphase-promoting complex, during meiotic maturation of swine oocytes.
Yamamuro T; Kano K; Naito K
Biol Reprod; 2008 Dec; 79(6):1202-9. PubMed ID: 18753608
[TBL] [Abstract][Full Text] [Related]
8. PRL-3 Promotes Ubiquitination and Degradation of AURKA and Colorectal Cancer Progression via Dephosphorylation of FZR1.
Zhang C; Qu L; Lian S; Meng L; Min L; Liu J; Song Q; Shen L; Shou C
Cancer Res; 2019 Mar; 79(5):928-940. PubMed ID: 30498084
[TBL] [Abstract][Full Text] [Related]
9. Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myeloma.
Crawford LJ; Anderson G; Johnston CK; Irvine AE
Oncotarget; 2016 Oct; 7(43):70481-70493. PubMed ID: 27655696
[TBL] [Abstract][Full Text] [Related]
10. Anaphase-Promoting Complex Adaptor FZR1/CDH1 Blocks BRAF Signaling Both by Targeting BRAF for Proteolytic Degradation and by Disrupting BRAF Dimerization.
Zhang C; Bollag G
Cancer Discov; 2017 Apr; 7(4):356-358. PubMed ID: 28373167
[TBL] [Abstract][Full Text] [Related]
11. A novel human Cdh1 mutation impairs anaphase promoting complex/cyclosome activity resulting in microcephaly, psychomotor retardation, and epilepsy.
Rodríguez C; Sánchez-Morán I; Álvarez S; Tirado P; Fernández-Mayoralas DM; Calleja-Pérez B; Almeida Á; Fernández-Jaén A
J Neurochem; 2019 Oct; 151(1):103-115. PubMed ID: 31318984
[TBL] [Abstract][Full Text] [Related]
12. APC/C and retinoblastoma interaction: cross-talk of retinoblastoma protein with the ubiquitin proteasome pathway.
Ramanujan A; Tiwari S
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27402801
[TBL] [Abstract][Full Text] [Related]
13. The APC/C activator FZR1 coordinates the timing of meiotic resumption during prophase I arrest in mammalian oocytes.
Holt JE; Tran SM; Stewart JL; Minahan K; García-Higuera I; Moreno S; Jones KT
Development; 2011 Mar; 138(5):905-13. PubMed ID: 21270054
[TBL] [Abstract][Full Text] [Related]
14. Relapsed B-acute lymphoblastic leukemia with aberrant myeloperoxidase expression following CAR T-cell therapy: A diagnostic challenge.
Li N; Wang SA; Lin P; Jabbour E; Thompson P; Chen Z; Li S; Xu J; You MJ; Bueso-Ramos CE; Medeiros LJ; Yin CC
Am J Hematol; 2019 Sep; 94(9):1049-1051. PubMed ID: 30916805
[No Abstract] [Full Text] [Related]
15.
Hormann FM; Hoogkamer AQ; Beverloo HB; Boeree A; Dingjan I; Wattel MM; Stam RW; Escherich G; Pieters R; den Boer ML; Boer JM
Haematologica; 2019 Oct; 104(10):e455-e459. PubMed ID: 30872366
[No Abstract] [Full Text] [Related]
16. Insufficiency of FZR1 disturbs HSC quiescence by inhibiting ubiquitin-dependent degradation of RUNX1 in aplastic anemia.
Zhou C; Kuang M; Liu Z; Jia X; Chen Z; Liu Y; Li Z; Wu W; Ma L; Chen J; Hou Y
Leukemia; 2022 Mar; 36(3):834-846. PubMed ID: 34635784
[TBL] [Abstract][Full Text] [Related]
17. Activation of Cdh1-dependent APC is required for G1 cell cycle arrest and DNA damage-induced G2 checkpoint in vertebrate cells.
Sudo T; Ota Y; Kotani S; Nakao M; Takami Y; Takeda S; Saya H
EMBO J; 2001 Nov; 20(22):6499-508. PubMed ID: 11707420
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of SALL4 in acute B cell lymphoblastic leukemia: mechanism, function, and implication for a potential novel therapeutic target.
Ueno S; Lu J; He J; Li A; Zhang X; Ritz J; Silberstein LE; Chai L
Exp Hematol; 2014 Apr; 42(4):307-316.e8. PubMed ID: 24463278
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia.
Iacobucci I; Di Rorà AG; Falzacappa MV; Agostinelli C; Derenzini E; Ferrari A; Papayannidis C; Lonetti A; Righi S; Imbrogno E; Pomella S; Venturi C; Guadagnuolo V; Cattina F; Ottaviani E; Abbenante MC; Vitale A; Elia L; Russo D; Zinzani PL; Pileri S; Pelicci PG; Martinelli G
J Hematol Oncol; 2015 Nov; 8():125. PubMed ID: 26542114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
